Enjuvia

This page contains recent news articles, when available, and an overview of Enjuvia but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Barr gets nod to market estrogen drug for new indication  -  Apr 30, 2007
The company said the drug for the new indication will be in a 0.9 mg tablet dosage strength and will be added to its existing Enjuvia product line in ... Reuters

Barr Launches Menopause Treatment  -  May 8, 2006
Enjuvia is made from a blend of 10 synthetic estrogen substances derived from plants. ... Barr, based in Woodcliff Lake, said Enjuvia now is available in ... San Francisco Chronicle

… Development; FDA grants approval for Enjuvia for vasomotor symptoms  -  Jan 25, 2005
2005 JAN 25 - (NewsRx.com & NewsRx.net) -- Barr Pharmaceuticals, Inc., (BRL) announced that its subsidiary, Duramed Pharmaceuticals, Inc., has received US ... Pay-Per-View - Science Letter - Factiva, from Dow Jones

… Launches New Indication for ENJUVIA(TM) (Synthetic Conjugated …  -  Oct 2, 2007
WOODCLIFF LAKE, NJ, Oct. 2 /PRNewswire-FirstCall/ -- Duramed Pharmaceuticals, Inc., a subsidiary of Barr Pharmaceuticals, Inc. , announced today the launch ... Free with registration - PR Newswire - AccessMyLibrary.com

Press Release: Duramed's ENJUVIA(TM) (Synthetic Conjugated …  -  Apr 30, 2007
Duramed's ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) Tablets Receives Two New FDA Approvals. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Business Update; Duramed's ENJUVIA (synthetic conjugated estrogens, …  -  Jun 7, 2006
2006 JUN 7 - (NewsRx.com) -- Duramed Pharmaceuticals, Inc., a subsidiary of Barr Pharmaceuticals, Inc. (BRL), announced that the company's ENJUVIA ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

… Development; FDA grants approval for Enjuvia for vasomotor symptoms  -  Jan 29, 2005
2005 JAN 29 - (NewsRx.com & NewsRx.net) -- Barr Pharmaceuticals, Inc., (BRL) announced that its subsidiary, Duramed Pharmaceuticals, Inc., has received US ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones

Press Release: Duramed's ENJUVIA(TM) (Synthetic Conjugated …  -  May 8, 2006
Duramed's ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) Now Available in Pharmacies Nationwide. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Article: Enjuvia for vaginal dryness.(PRODUCTS) - Skin & Allergy News...  -  Jun 1, 2007
Enjuvia for vaginal dryness.(PRODUCTS) ... find Skin & Allergy News articles. Enjuvia (synthetic conjugated estrogens, B) is approved for the treatment of ... Pay-Per-View - Skin & Allergy News - HighBeam Research

… agency of record for Duramed's Enjuvia (synthetic conjugated...  -  Mar 1, 2005
Adient is agency of record for Duramed's Enjuvia (synthetic conjugated estrogens) and a related product. Free with registration - Pharmaceutical Executive - AccessMyLibrary.com

Enjuvia Shows Promise for Treating Vulvovaginal Atrophy in...  -  Oct 26, 2006
October 26, 2006 (New Orleans) —A study of healthy postmenopausal women presented here at the annual meeting of the American Society for Reproductive ... Medscape

Enjuvia for vaginal dryness.(PRODUCTS)  -  Jun 1, 2007
Enjuvia (synthetic conjugated estrogens, B) is approved for the treatment of moderate to severe ... Enjuvia is approved in a new tablet strength, 0.9 mg. ... Free with registration - Skin & Allergy News - AccessMyLibrary.com

Barr Pharmaceuticals Inc. US FDA approves NDA for synthetic …  -  Jan 19, 2005
The Company's Enjuvia product line includes the lowest dose, plant-derived, synthetic conjugated estrogen product approved for the treatment of vasomotor ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones

Enjuvia for vaginal dryness.(PRODUCTS)(Brief article)  -  Sep 1, 2007
Enjuvia (synthetic conjugated estrogens, B) is approved for the treatment of moderate to severe vaginal dryness and pain with intercourse, ... Free with registration - Internal Medicine News - AccessMyLibrary.com

Hormone Replacement Therapy; US FDA approves NDA for synthetic …  -  Jan 22, 2005
The Company's Enjuvia product line includes the lowest dose, plant-derived, synthetic conjugated estrogen product approved for the treatment of vasomotor ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones

… Launches New Indication for ENJUVIA(TM) (Synthetic Conjugated …  -  Oct 2, 2007
Duramed Launches New Indication for ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) at North American Menopause Society Annual Meeting. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

Enjuvia for vaginal dryness.(PRODUCTS)  -  Jun 1, 2007
Enjuvia (synthetic conjugated estrogens, B) is approved for the treatment of moderate to severe vaginal dryness and pain with intercourse, and symptoms of ... $4.95 - Skin & Allergy News - ECNext

Enjuvia for vaginal dryness.(PRODUCTS)(Brief article) | Article from ...  -  Sep 1, 2007
Enjuvia for vaginal dryness.(PRODUCTS)(Brief article) ... find Internal Medicine News articles. Enjuvia (synthetic conjugated estrogens, B) is approved for ... Pay-Per-View - Internal Medicine News - HighBeam Research

Enjuvia.  -  Jun 1, 2007
Synthetic conjugated estrogens, B (Enjuvia, Duramed) was approved for the treatment of moderate-to-severe vaginal dryness and pain with intercourse, ... $9.94 - Formulary - Alacra Store

Enjuvia.(Recently Approved)  -  Jun 1, 2007
Enjuvia (synthetic conjugated estrogens, B) has been approved for a new use: the treatment of moderate-to-severe vaginal dryness and pain with intercourse, ... $4.95 - Pharmaceutical Representative - ECNext

Pain During Sex & Vaginal Dryness  -  Feb 10, 2008
ENJUVIAâ„¢ is also approved for treatment of moderate-to-severe vasomotor ... Important Information: ENJUVIA is a medicine that contains estrogen hormones. ... Imperial Valley News

Hormone Replacement Therapy; US FDA approves NDA for synthetic …  -  Jan 17, 2005
The Company's Enjuvia product line includes the lowest dose, plant-derived, synthetic conjugated estrogen product approved for the treatment of vasomotor ... Pay-Per-View - Biotech Business Week - Factiva, from Dow Jones

Senior Health Report: Menopause  -  May 16, 2006
A plant-derived formulation, Enjuvia contains a blend of 10 synthetic estrogenic ... Enjuvia tablets are available in a variety of dosage strengths ... Senior Health Report

Barr introduces a plant-derived drug to ease menopause | Article from...  -  May 9, 2006
Enjuvia is made from a blend of 10 synthetic estrogen substances derived from plants. ... Barr, based in Woodcliff Lake, said Enjuvia now is available in ... Pay-Per-View - The Record - HighBeam Research

Press Release: New Data From the Women's Health Initiative Study Show...  -  Apr 11, 2006
Article: Barr Receives FDA Approval for Enjuvia(TM) (Synthetic . ... Enjuvia synthetic conjugated estrogens product, and two ... known or suspected breast ... Pay-Per-View - PR Newswire - HighBeam Research

Generic Razadyne.(RX RETAIL PHARMACY: Generic Drugs)(Barr …  -  Oct 27, 2008
Article: Enjuvia approved.(RXs)(Barr Pharmaceuticals Inc.)(Brief Article) ... Barr Pharmaceuticals Inc. has been given clearance to market Enjuvia for ... Pay-Per-View - Chain Drug Review - HighBeam Research

Breast ca-related symptoms are hard to treat: vaginal dryness,...  -  Apr 1, 2008
Article: Enjuvia for vaginal dryness.(PRODUCTS)(Brief ... ... Enjuvia (synthetic conjugated estrogens, B) is approved for the treatment of moderate to ... Pay-Per-View - Internal Medicine News - HighBeam Research

Q4 2006 Barr Pharmaceuticals, Inc. Earnings Conference Call - Part 2.  -  Aug 15, 2006
RICH SILVER, ANALYST, LEHMAN BROTHERS: On ENJUVIA, would you break out the sales of ENJUVIA ... BRUCE DOWNEY: They've been very mock -- the ENJUVIA sales, ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

NEW JERSEY BRIEFS | Article from The Record (Bergen County, NJ) | …  -  May 1, 2007
Enjuvia was introduced in November 2006. — By The Record's staff. ***. American Bancorp says it will buy back stock. BLOOMFIELD — American Bancorp of New ... Pay-Per-View - The Record - HighBeam Research

Act locally and use behavioral approach for vaginal dryness. |...  -  Sep 15, 2005
Article: Enjuvia for vaginal dryness.(PRODUCTS)(Brief ... ... Enjuvia (synthetic conjugated estrogens, B) is approved for the treatment of moderate to ... Pay-Per-View - Internal Medicine News - HighBeam Research

FINAL TRANSCRIPT  -  May 21, 2008
ENJUVIA, a second-generation synthetic conjugated estrogen product that is now competing with ... Its primary focus is on SEASONIQUE, ENJUVIA, and Plan B. ... $54.00 - Thomson StreetEvents - Alacra Store

Press Release: More Clinical Data Required to Support European …  -  Mar 12, 2008
ENJUVIA ... percent of menopausal women suffer from vasomotor symptoms, such as hot flushes, uncontrollable ... that contributes to the relief of vasomotor ... Pay-Per-View - PR Newswire - HighBeam Research

Barr Reports Third Quarter Fiscal 2006 GAAP Earnings of $0.70 Per …  -  May 4, 2006
We also invested in preparing for the launch of our Enjuvia(TM) hormone therapy product line in April and submitted our labeling for our SEASONIQUE(TM) ... Free with registration - PR Newswire - AccessMyLibrary.com

Press Release: Crush or Flush(TM) Launches Today: The New Way to …  -  Jan 16, 2007
These hot flushes are often so severe that ... menopausal symptoms such as hot flushes can be extremely debilitating ... New Jersey. ENJUVIA(TM) ... Pay-Per-View - PR Newswire - HighBeam Research

Factiva Search  -  Jan 10, 2005
ENJUVIA Barr Labs supplemental approval, USA (hormone deficiency).(BARR Laboratories Inc.)(Brief Article). 10 January, 2005 R & D Focus Drug News ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones

Barr Pharmaceuticals, Inc. at Credit Suisse Annual Health Care …  -  Nov 15, 2006
We have the new launch of ENJUVIA, the new launch of SEASONIQUE, PlanB, going LTC. Very significant development and within the last year we have acquired ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Barr's Receives Not Approvable Letter for Bijuva(TM) Vaginal Cream.  -  Apr 26, 2005
The Company currently has approval for its Enjuvia line 0.3 mg, 0.45 mg, 0.625 mg and 1.25 mg tablet strengths for the treatment of moderate to severe ... $4.95 - PR Newswire - ECNext

Female condoms can be a viable alternative.(Female Health Co. …  -  Oct 24, 2005
The transaction includes the new drug application ... intellectual property related to Endeavor's Enjuvia and two female health products in early stages of ... Pay-Per-View - Chain Drug Review - HighBeam Research

Teva negotiating $7.5 billion buyout of US generic firm  -  Jul 20, 2008
Barr's Enjuvia hormonal treatment for menopause would also be a nice addition to the Teva medicine chest. Another benefit for Teva is Barr's access to the ... Ha'aretz

Article: Barr Launches Menopause Treatment - AP Online | HighBeam …  -  May 8, 2006
Enjuvia is made from a blend of 10 synthetic estrogen substances derived from plants. ... Read all of this article with a FREE trial ... Pay-Per-View - AP Online - HighBeam Research

Factiva Search  -  May 15, 2006
Duramed Pharmaceuticals, a wholly-owned subsidiary of Barr Labs, announced on 8 May 2006 that it has launched ENJUVIA ... Copyright 2006 Gale Group Inc. All ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones

Event Brief of Q1 2007 Barr Pharmaceuticals, Inc. Earnings Conference...  -  May 9, 2007
After close of 1Q07, secured two approvals for ENJUVIA, new indication, ... See ENJUVIA, second generation synthetic estrogen as very strong performer going ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Press Release: Study Data Results Showed Desvenlafaxine Significantly...  -  Oct 15, 2007
ENJUVIA ... percent of menopausal women suffer from vasomotor symptoms, such as hot flushes, uncontrollable ... that contributes to the relief of vasomotor ... Pay-Per-View - PR Newswire - HighBeam Research

Article: NO DECISION ON MORNING-AFTER PILL.(FRONT) - The Capital …  -  Jan 22, 2005
Article: Enjuvia approved.(RXs)(Barr Pharmaceuticals ... Chain Drug Review; June 7, 2004 ; 545 words ...Barr Pharmaceuticals Inc. has received Food and Drug ... Pay-Per-View - Capital Times - HighBeam Research

שלמה ×™× ×?×™ בכנס משקיעי טבע בניו יורק: ×?זילקט ×™×”×™×” מוצר ל×? פחות ×’  -  Jul 21, 2008
...מוצריה של ב×?ר בתחו×? ברי×?ות ×”×?ישה, כמו גלולת היו×? ש×?חרי Plan B, ומוצרי×? ×?חרי×? כמו Enjuvia. ... ×”×?רץ

Medpharm: FDA approves Plan B, who owns it?  -  Aug 25, 2006
This includes five oral contraceptives, including Plan B, and ENJUVIA, a once-daily oral estrogen therapy for treatment of vasomotor symptoms associated ... Manufacturer.com

Article: OTC Morning-After Pill Decision Delayed - AP Online |...  -  Jan 24, 2005
Article: Enjuvia approved.(RXs)(Barr Pharmaceuticals ... Chain Drug Review; June 7, 2004 ; 545 words ...Barr Pharmaceuticals Inc. has received Food and Drug ... Pay-Per-View - AP Online - HighBeam Research

טבע מחזקת ההובלה ב×?רה"ב: במו"מ לרכישת ב×?ר  -  Jul 18, 2008
...גלולת היו×? ש×?חרי PLAN B, ו-Enjuvia, שנועדה לטיפול הורמונלי בתופעות הקשורות בהפסקת הווסת. ... ×”×?רץ

Generic allegra-D approved.(PRODUCTS)(Brief Article) | Article from …  -  Jul 1, 2005
Article: Enjuvia for vaginal dryness.(PRODUCTS)(Brief article) ... Enjuvia is also approved in a new tablet strength, 0.9 mg. For more information, contact ... Pay-Per-View - Internal Medicine News - HighBeam Research

Article: FDA Eases Limits on Plan B Sales - AP Online | HighBeam …  -  Aug 24, 2006
Article: Enjuvia approved.(RXs)(Barr Pharmaceuticals ... Chain Drug Review; June 7, 2004 ; 545 words ...Barr Pharmaceuticals Inc. has received Food and Drug ... Pay-Per-View - Associated Press/AP Online - HighBeam Research

Clonazepam disintegrating tablets.(Products)(Brief Article) | Article...  -  Nov 1, 2005
Article: Enjuvia approved.(Products)(Brief Article) ... Enjuvia (synthetic conjugated estrogens, B) in 0.625 mg and 1.25 mg tablets is approved for moderate ... Pay-Per-View - Family Practice News - HighBeam Research

Estrogen replacement therapy (ERT)  -  May 16, 2008
Enjuvia contains plant-based, rather than animal-based, estrogen. Risks and benefits are thought to be the same for both types of estrogen. ... MSN Health & Fitness

Barr confirms FTC lawsuit.(Barr Pharmaceuticals Inc.)(Brief Article)...  -  Nov 21, 2005
Article: Enjuvia approved.(RXs)(Barr Pharmaceuticals ... Chain Drug Review; June 7, 2004 ; 545 words ...Barr Pharmaceuticals Inc. has received Food and Drug ... Pay-Per-View - Chain Drug Review - HighBeam Research

MORNING AFTER PILL Pictures from August 22, 2007 | HighBeam …  -  Aug 22, 2007
Article: Enjuvia approved.(RXs)(Barr Pharmaceuticals ... Chain Drug Review; June 7, 2004 ; 545 words ...Barr Pharmaceuticals Inc. has received Food and Drug ... Pay-Per-View - AP Images - HighBeam Research

Sorry, Somers, 'bioidentical' not another word for 'safe'  -  Dec 12, 2006
The prescription products Cenestin and Enjuvia are conjugated estrogens that are laboratory-manufactured from plants. This estrogen is derived from natural ... San Diego Union - Tribune - San Diego Union Tribune

Menopause Symptoms May Hamper Sex  -  Oct 5, 2007
The study was funded by the menopause education group Red Hot Mamas and Duramed Pharmaceuticals, which makes the estrogen drug Enjuvia for menopausal ... CBS News

DAILY CHECKUP  -  May 10, 2006
Enjuvia is made from a blend of 10 synthetic estrogen substances derived from plants. The once-daily pills come in four doses, and the estrogen is released ... Pay-Per-View - Lexington Herald Leader - Factiva, from Dow Jones

Q3 2006 Barr Pharmaceuticals, Inc. Earnings Conference Call - Final.  -  Nov 8, 2006
One, the $6 million payment that I mentioned earlier, also, increased sales and marketing expenses related to the launches of our SEASONIQUE and ENJUVIA ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Barr Reports GAAP Earnings of $0.49 Per Share for Quarter Ended …  -  Sep 30, 2006
...including the recently launched SEASONIQUE and ENJUVIA(TM) products; (2) higher IT consulting costs related to the implementation of our SAP enterprise ... prnewswire.com

Plan B(R) OTC Now Available in Pharmacies Nationwide  -  Nov 17, 2006
These include the SEASONIQUE(TM) extended-regimen oral contraceptive; Mircette(R) oral contraceptive; ENJUVIA(TM) hormone therapy; and the ParaGard(R) IUC. ereleases.com

Event Brief of Barr Pharmaceuticals, Inc. Conference Call to discuss...  -  May 12, 2006
With Cenestin and impending launch of ENJUVIA. 2. Switch to Plan B is still ongoing. 3. Working on Bijuva cream product. 4. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

Q4 2006 Barr Pharmaceuticals, Inc. Earnings Conference Call - Final.  -  Aug 15, 2006
Significantly, we launched the -- received approval and launched the ENJUVIA hormone replacement product. We received approval for our SEASONIQUE extended ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

CommonHealth: the WPP network gets its ducks in line with a …  -  Jul 1, 2006
In an effort to offset its 2005 losses, Quantum picked up DTC on Duramed's Enjuvia for vasomotor symptoms, as well as Provigil and Nuvigil from Cephalon. ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com

Senior Health Report: Menopause  -  Jan 3, 2007
Duramed Introduces Enjuvia, Synthetic Estrogen to Treat Moderate-to-Severe Menopausal Symptons: Plant derived formulation provides women with new low-dose ... Senior Health Report

Barr Pharmaceuticals, Inc. at Wachovia Securities Small and Mid-Cap …  -  Jan 31, 2007
Duramed is our North American proprietary business through which we sell Plan B, SEASONIQUE, ENJUVIA and the like and then Barr Laboratories is the ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Event Brief of Q3 2006 Barr Pharmaceuticals, Inc. Earnings Conference...  -  Nov 8, 2006
Increased sales and marketing expenses related to the launches of SEASONIQUE and ENJUVIA products. 3. IT expense related to the SAP installation both in ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

Fact Sheet of Barr Pharmaceuticals, Inc. and PLIVA dd  -  Jun 27, 2006
SEASONIQUE(TM) Extended-Cycle Oral Contraceptive, ParaGard(R) IUD, ENJUVIA(TM) Hormone Therapy Pipeline 39 ANDAs at US FDA 21 ANDAs at US FDA 2 NDAs at ... Free with registration - PR Newswire - AccessMyLibrary.com

Barr Pharmaceuticals, Inc. at Wachovia Securities Small and Mid-Cap …  -  Jan 3, 2007
Duramed is our North American proprietary business through which we sell Plan B, SEASONIQUE, ENJUVIA and the like and then Barr Laboratories is the ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

Adient, CommonHealth's professional advertising and promotion unit,...  -  Feb 1, 2005
...has been named professional agency of record by Duramed Pharmaceuticals for a pair of proprietary products in women's healthcare: Enjuvia tablets and a ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com

Event Brief of Q4 2005 Barr Pharmaceuticals, Inc. Earnings Conference...  -  Sep 8, 2005
4. BRL expects revenue growth from the existing proprietary. of SEASONALE, Plan B, and the launch of Enjuvia in 2H05. 1. All of this is. Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

New dosing.(Brief Article)  -  Jan 24, 2005
Enjuvia tablets (synthetic conjugated estrogens, B) are a blend of 10 synthetic estrogenic substances, including delta 8,9-dehydroestrone sulfate. ... Free with registration - Drug Topics - AccessMyLibrary.com

Event Brief of Q4 2006 Barr Pharmaceuticals, Inc. Earnings Conference...  -  Aug 15, 2006
BRL received approval and launched the ENJUVIA hormone replacement product. 4. The Co. received approval for the SEASONIQUE extended regimen oral ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

TRANSLATING THE TECH TALK: NATURAL VS. BIOIDENTICAL  -  Nov 23, 2006
The prescription products Cenestin and Enjuvia are conjugated estrogens that are laboratory-manufactured from plants. This estrogen is derived from natural ... $2.95 - Sun Herald - NewsBank

Erie Times-News : News<br>  -  Feb 26, 2007
Enjuvia. Estrace. Estratest. FemHRT. Ogen. Prefest. Premarin. Prempro. Premphase. PATCHES. Alora. Climara. CombiPatch. Esclim. Estraderm. Fempatch. Menostar ... $2.95 - Erie Times-News - NewsBank

Barr Reports Second Quarter 2007 GAAP Earnings of $0.41 Per Share; …  -  Aug 8, 2007
During the quarter, the Company received two FDA approvals related to its ENJUVIA(TM) (synthetic conjugated estrogens, B) product. ... $4.95 - PR Newswire - ECNext

Top 50 packagers: pharmaceutical.(TOP 200 PACKAGERS)(Company …  -  Jul 1, 2007
Precedex 41 Barr Pharmaceuticals Inc. Enjuvia; Seasonique; Plan 1 Woodcliff Lake, N.J. B; Seasonale; Mircette; ParaGard 42 TAP Pharmaceutical Prevacid; ... Free with registration - Food & Drug Packaging - AccessMyLibrary.com

Barr Reports GAAP Earnings of $2.03 Per Share for Fiscal 2005 and …  -  Sep 8, 2005
...including the anticipated launch of our Enjuvia(R) hormone therapy product; landmark opportunities in several of our patent challenges, including the ... $4.95 - PR Newswire - ECNext

Business Update; Pharmaceutical firm selects ad agency for estrogen …  -  Jan 17, 2005
...for two proprietary products in women's healthcare: Enjuvia (synthetic conjugated estrogens, B) tablets and a synthetic conjugated estrogens vaginal ... Pay-Per-View - Pharma Business Week - Factiva, from Dow Jones

Merger and Acquisition Scenario  -  May 5, 2007
These products include SEASONALE and SEASONIQUE extended-cycle oral contraceptive products, and Cenestin (synthetic conjugated estrogens, A) and ENJUVIA ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  May 19, 2007
These products include SEASONALE and SEASONIQUE extended-cycle oral contraceptive products, and Cenestin (synthetic conjugated estrogens, A) and ENJUVIA ... $250.00 - Revere Reports - Revere

Popular Brands of Menopause Hormones | Article from AP Online | …  -  Feb 25, 2007
Popular Brands of Menopause Hormones ... find AP Online articles. These are popular brands of menopause hormones. PILLS Activella Angeliq Cenestin Enjuvia ... Pay-Per-View - Associated Press/AP Online - HighBeam Research

Article: The Center for Reproductive Rights.(Update) - Medical...  -  Sep 1, 2006
Barr Pharmaceuticals has received U.S. regulatory approval for Enjuvia, a new female hormone replacement product. The FDA approved the plant-derived product ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Factiva Search  -  Jan 26, 2005
Barr Pharmaceuticals, Inc. FDA grants approval for Enjuvia for vasomotor symptoms. 26 January, 2005 Biotech Week. 2005 JAN 26 - (NewsRx.com & NewsRx.net) ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones

Merger and Acquisition Scenario  -  Nov 25, 2006
These products include SEASONALE and SEASONIQUE extended-cycle oral contraceptive products, and Cenestin (synthetic conjugated estrogens, A) and ENJUVIA ... $250.00 - Revere Reports - Revere

Associated Press Archive: Glance: Popular brands of menopause …  -  Feb 25, 2007
Enjuvia. Estrace. Estratest. FemHRT. Ogen. Prefest. Premarin. Prempro. Premphase. PATCHES. Alora. Climara. CombiPatch. Esclim. Estraderm. Fempatch. Menostar ... $2.95 - Associated Press Archive - NewsBank

Merger and Acquisition Scenario  -  Jan 27, 2007
These products include SEASONALE and SEASONIQUE extended-cycle oral contraceptive products, and Cenestin (synthetic conjugated estrogens, A) and ENJUVIA ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  May 5, 2007
These products include SEASONALE and SEASONIQUE extended-cycle oral contraceptive products, and Cenestin (synthetic conjugated estrogens, A) and ENJUVIA ... $250.00 - Revere Reports - Revere

Transcending trendiness: naming your brand for today's market: in a …  -  Oct 1, 2007
When it came to pharmaceuticals, the menopause drug Enjuvia was number one, according to 25.1 percent of respondents. Reconcile, for anxiety in dogs, ... $9.94 - Pharmaceutical Executive - Alacra Store

Duramed Pharmaceuticals, Inc. Pharmaceutical firm selects ad agency...  -  Jan 19, 2005
...for two proprietary products in women's healthcare: Enjuvia (synthetic conjugated estrogens, B) tablets and a synthetic conjugated estrogens vaginal ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones

Press Release: Trading Alert for Barr Pharmaceuticals Inc. - M2...  -  Feb 28, 2007
Duramed Pharmaceuticals subsidiary makes branded drugs, including extended-cycle oral contraceptive SEASONALE and estrogen-replacement therapy ENJUVIA. ... Pay-Per-View - M2 Presswire - HighBeam Research

Press Release: Barr Reports GAAP Earnings of $3.12 Per Share for...  -  Aug 15, 2006
Among the other highlights for fiscal 2006 were the launch of our ENJUVIA(TM) hormone therapy, approval for our SEASONIQUE(TM) extended-cycle oral ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Wyeth Presents Phase 3 Data for Pristiq, an …  -  May 9, 2007
ENJUVIA ... percent of menopausal women suffer from vasomotor symptoms, such as hot flushes, uncontrollable ... that contributes to the relief of vasomotor ... Pay-Per-View - PR Newswire - HighBeam Research

Merger and Acquisition Scenario  -  Apr 7, 2007
These products include SEASONALE and SEASONIQUE extended-cycle oral contraceptive products, and Cenestin (synthetic conjugated estrogens, A) and ENJUVIA ... $250.00 - Revere Reports - Revere

Article: New indication for Fragmin.(PRODUCTS)(Brief article) -...  -  Aug 1, 2007
Barr Pharmaceuticals Inc. has been given clearance to market Enjuvia for treating vaginal dryness and pain with intercourse associated with menopause. ... Pay-Per-View - Internal Medicine News - HighBeam Research

Article: Adient, CommonHealth's professional advertising and promotion...  -  Feb 1, 2005
...has been named professional agency of record by Duramed Pharmaceuticals for a pair of proprietary products in women's healthcare: Enjuvia tablets and a ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Adient, CommonHealth's professional advertising and promotion unit,...  -  Feb 1, 2005
...has been named professional agency of record by Duramed Pharmaceuticals for a pair of proprietary products in women's healthcare: Enjuvia tablets and a ... $9.94 - Medical Marketing & Media - Alacra Store

Article: New indication.(RXs)(Brief article) - Chain Drug Review | …  -  May 21, 2007
Barr Pharmaceuticals Inc. has been given clearance to market Enjuvia for treating vaginal dryness and pain wi... Pay-Per-View - Chain Drug Review - HighBeam Research

Trade Alert for Barr Pharmaceuticals Inc.  -  May 10, 2007
These products primarily include SEASONIQUE, an extended-cycle oral contraceptive; ENJUVIA, a hormone therapy product; ParaGard T 380A, an IUD contraceptive ... $4.95 - M2 Presswire - ECNext

Merger and Acquisition Scenario  -  Dec 16, 2006
These products include SEASONALE and SEASONIQUE extended-cycle oral contraceptive products, and Cenestin (synthetic conjugated estrogens, A) and ENJUVIA ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Dec 16, 2006
These products include SEASONALE and SEASONIQUE extended-cycle oral contraceptive products, and Cenestin (synthetic conjugated estrogens, A) and ENJUVIA ... $250.00 - Revere Reports - Revere





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy